Experimental data show the potential actions of propolis against viral targets such as TMPRSS2, ACE2 receptor and PAK1, which justifies the experimental use of EPP-AF and results in new perspectives to treat diseases that lead to immuno-inflammatory dysregulation6,11. The gene discussed is PAK1; the disease is atrial fibrillation.